Hot Tuna has been consistent in his view yet QIN has survived a...

Hot Tuna has been consistent in his view yet QIN has survived a much more perilous period in 2011 when CBA pulled the plug.

Now the coy is on the cusp of volume high value product supply of the traditional market with its major competitor facing a reduced supply due to over harvesting. QIN's other developing market i.e. organic medical products is also maturing as its proceeds through FDA Stage 3 for one product and Stage 2 for others.

As far as I can see the long term fundamentals are sound and the issue revolves around short term liquidity. So the deal forthcoming needs to address that plus provide the best outcome possible for existing shareholders.

I await this and if it involves a cap raising I will favourably review participating, Roll on next week

All IMO and DYOR